Vimta Labs Q2 FY27 results: Total income Rs 114.90 cr, PAT Rs 20.60 cr
Vimta Labs’ Q2 FY27 total income rose to Rs 114.90 cr and PAT to Rs 20.60 cr versus Rs 104.50 cr and Rs 19.90 cr in Q2 FY26, per the statement of financial results.
Key takeaways
- Total Income Rs 114.90 cr in Q2 FY27 vs Rs 104.50 cr in Q2 FY26
- Revenue from Operations Rs 112.00 cr vs Rs 101.80 cr a year earlier
- EBIDTA Rs 40.80 cr in Q2 FY27 vs Rs 36.90 cr in Q2 FY26
- PAT Rs 20.60 cr in Q2 FY27 vs Rs 19.90 cr in Q2 FY26
- Basic EPS 4.6 in Q2 FY27 vs 4.5 in Q2 FY26
Q2 FY27 · standalone
| Metric | Sep 2026 | Sep 2025 | Change |
|---|---|---|---|
| Revenue | Rs 112.00 cr | Rs 101.80 cr | +10.0% |
| PAT | Rs 20.60 cr | Rs 19.90 cr | +3.5% |
As reported in the filing. Figures are transcribed, not computed.
What the numbers show
- Net margin was 18.39% of revenue, down 115 bps from 19.55%.
Key Q2 FY27 numbers (per the statement of financial results – Profit & Loss Statement)
- Total Income: Rs 114.90 cr (Q2 FY26: Rs 104.50 cr)
- Revenue from Operations: Rs 112.00 cr (Q2 FY26: Rs 101.80 cr)
- Total Expenses: Rs 74.10 cr (Q2 FY26: Rs 67.60 cr)
- Material and Testing Costs: Rs 26.20 cr (Q2 FY26: Rs 20.10 cr)
- Employee benefits expense: Rs 30.70 cr (Q2 FY26: Rs 28.60 cr)
- Other expenses: Rs 17.30 cr (Q2 FY26: Rs 18.90 cr)
- EBIDTA: Rs 40.80 cr (Q2 FY26: Rs 36.90 cr)
- Finance costs: Rs 0.40 cr (Q2 FY26: Rs 0.40 cr)
- Depreciation expense: Rs 12.90 cr (Q2 FY26: Rs 10.20 cr)
- PBT: Rs 27.50 cr (Q2 FY26: Rs 26.30 cr)
- PAT: Rs 20.60 cr (Q2 FY26: Rs 19.90 cr)
- Basic EPS (INR): 4.6 (Q2 FY26: 4.5)
For the quarter ended 30 September 2026 (Q2 FY27), Vimta Labs reported Total Income of Rs 114.90 cr, up from Rs 104.50 cr in the corresponding quarter a year earlier, according to the Profit & Loss Statement in the statement of financial results. Revenue from Operations increased to Rs 112.00 cr from Rs 101.80 cr over the same period.
On the cost side, Total Expenses rose to Rs 74.10 cr in Q2 FY27 from Rs 67.60 cr in Q2 FY26. Within this, Material and Testing Costs increased to Rs 26.20 cr from Rs 20.10 cr, and Employee benefits expense moved to Rs 30.70 cr from Rs 28.60 cr. Other expenses were Rs 17.30 cr in Q2 FY27 compared with Rs 18.90 cr in Q2 FY26.
Operating performance, as captured by EBIDTA, was Rs 40.80 cr in Q2 FY27 versus Rs 36.90 cr in Q2 FY26. Finance costs were unchanged at Rs 0.40 cr year-on-year, while Depreciation expense increased to Rs 12.90 cr from Rs 10.20 cr.
After these charges, PBT for Q2 FY27 stood at Rs 27.50 cr, compared with Rs 26.30 cr in the same quarter of the previous year. PAT came in at Rs 20.60 cr versus Rs 19.90 cr in Q2 FY26, as shown in the statement of financial results. Basic EPS (INR) for the quarter was 4.6, slightly higher than 4.5 in Q2 FY26.
Track Vimta Labs Ltd-$
Cruxal reads every Vimta Labs Ltd-$ filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.
Get every filing that moves a stock
One email before the open, with the day's filings that actually shifted a price — the number, the source document and what the market did with it. Free, and you can unsubscribe from any issue.
Cruxal publishes market coverage for information only. Nothing here is investment advice.
